Previous Article | Next Article 
Journal of Clinical Microbiology, February 2007, p. 544-547, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.01728-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Rapid Detection and Identification of Metallo-ß-Lactamase-Encoding Genes by Multiplex Real-Time PCR Assay and Melt Curve Analysis
Rodrigo E. Mendes,1,2*
Katia A. Kiyota,2
Jussimara Monteiro,1,2
Mariana Castanheira,1
Soraya S. Andrade,1,2
Ana C. Gales,1
Antonio C. C. Pignatari,1 and
Sergio Tufik2,3
Laboratório Especial de Microbiologia Clínica and Laboratório ALERTA, Division of Infectious Disease, Federal University of São Paulo,1
AFIPMedicina Laboratorial, São Paulo,2
Department of Psychobiology, Federal University of São Paulo, São Paulo, Brazil3
Received 21 August 2006/
Returned for modification 26 September 2006/
Accepted 30 October 2006

ABSTRACT
Metallo-ß-lactamase enzymes (MßL) are encoded
by transferable genes, which appear to spread rapidly among
gram-negative bacteria. The objective of this study was to develop
a multiplex real-time PCR assay followed by a melt curve step
for rapid detection and identification of genes encoding MßL-type
enzymes based on the amplicon melting peak. The reference sequences
of all genes encoding IMP and VIM types, SPM-1, GIM-1, and SIM-1
were downloaded from GenBank, and primers were designed to obtain
amplicons showing different sizes and melting peak temperatures
(
Tm). The real-time PCR assay was able to detect all MßL-harboring
clinical isolates, and the
Tm-assigned genotypes were 100% coincident
with previous sequencing results. This assay could be suitable
for identification of MßL-producing gram-negative
bacteria by molecular diagnostic laboratories.

INTRODUCTION
Since the first report of acquired metallo-ß-lactamase
(MßL) in Japan in 1994 (
15), genes encoding IMP- and
VIM-type enzymes have spread rapidly among
Pseudomonas spp.
(
1,
5,
10,
13,
14,
16,
18,
22-
24),
Acinetobacter spp. (
3,
4,
17,
21,
29), and strains of
Enterobacteriaceae (
6,
8,
11,
12,
20,
28). Moreover, new MßL types have been described,
such as SPM (
25), GIM (
2), and, more recently, SIM (
9).
The prevalence of MßL-producing gram-negative bacilli has increased in some hospitals, particularly among clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. (21, 23, 27). Since MßL production may confer phenotypic resistance to virtually all clinically available ß-lactams, the continued spread of MßL is a major clinical concern (26). The aim of this study was to develop a multiplex real-time PCR assay followed by a melt curve step for rapid detection and identification of genes encoding the MßL-type enzymes so far described. The MßL type identification was based on the characteristic amplicon melting peak.

MATERIALS AND METHODS
MßL-harboring clinical isolates and MßL-negative control strains.
The strains used in this study are listed in Tables
1 and
2.
The MßL genotypes of the clinical isolates of gram-negative
nonfermentative and fermentative bacteria harboring MßL
were previously characterized by PCR and sequencing. When applicable,
these clinical isolates were also previously molecularly typed
to ensure that genetically unrelated strains were used. Additionally,
several American Type Culture Collection (ATCC; Manassas, VA)
reference strains and laboratory strains were used as MßL-negative
controls (Table
2).
View this table:
[in this window]
[in a new window]
|
TABLE 2. ATCC reference and laboratory strains of gram-negative bacteria used during the validation process as MßL-negative control strainsa
|
DNA preparation.
The microorganisms were grown on blood agar plates overnight
at 37°C to ensure colony purity. Three or four bacterial
colonies were taken from the blood agar plates and suspended
in 200 µl of DNase/RNase-free distilled water (Invitrogen,
CA). Two microliters of this suspension was used as templates
for further amplification.
Primer design.
The currently available reference sequences of the MßL-encoding IMP- and VIM-type (http://www.lahey.org/studies/), SPM-1 (AJ492820), GIM-1 (AJ620678), and SIM-1 (AY887066) genes were downloaded from GenBank (National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD). Based on the comprehensive analyses and alignments of each MßL type, primers were designed to yield amplicons showing different sizes and melting peak temperatures (Tm) separated by at least 1°C. Predicted amplicon sizes and Tm were determined by the Lasergene software package (DNASTAR, Madison, WI).
Additionally, a primer pair targeting the consensus region of the bacterial 16S rRNA gene was included in the reaction mixture as a PCR internal-control target. Primer pairs were evaluated in a single format (using a primer concentration of 0.5 µM) to ensure that they correctly amplified their respective loci and that the amplicons showed the expected Tm. Subsequently, the multiplex format was optimized by assaying different primer pair concentrations. The primer sequences, positions, and concentrations, and the sizes of the corresponding amplicons, are given in Table 3.
Multiplex real-time PCR.
Amplification was performed in a 48-µl mixture containing
25 µl of Platinum SYBR Green qPCR SuperMix (Platinum
Taq DNA polymerase, SYBR Green I dye, Tris-HCl, KCl, 6 mM MgCl
2,
400 µM dGTP, 400 µM dATP, 400 µM dCTP, 800
µM dUTP, uracil DNA glycosylase, and stabilizers) (Invitrogen,
CA), six pairs of primers at their respective concentrations
(Table
3), and 2 µl of the template by using the DNA Engine
Opticon 2 system (Bio-Rad Laboratories, CA). The PCR conditions
were as follows: initial denaturation at 94°C for 5 min;
35 cycles of 94°C for 20 s, 53°C for 45 s, and 72°C
for 30 s; and a melt curve step (from 68°C, gradually increasing
0.5°C/s to 95°C, with acquisition data every 1 s). Melt
curves were then converted into melting peaks by plotting the
negative derivative of fluorescence versus temperature (
dF2/
dT versus
T and
dF3/
dT versus
T).
Multiplex real-time PCR validation.
In order to assess the accuracy of the assay, 44 bacterial strains were blindly tested after real-time PCR optimization (Tables 1 and 2).
Multiplex real-time PCR sensitivity.
The sensitivity of the reaction was estimated by dilution experiments. Briefly, one representative of each MßL-harboring clinical isolate was suspended in DNase/RNase-free distilled water to a density corresponding to a McFarland turbidity standard of 1.0 (3 x 108 CFU/ml). These suspensions were used to prepare serial 10-fold dilutions using DNase/RNase-free distilled water.

RESULTS AND DISCUSSION
When different strains were submitted to the real-time PCR assay,
differences in the
Tm of the amplicons were observed for strains
harboring
blaIMP-type allelic variants (from 76.0°C to 77.5°C)
as well as for those harboring
blaVIM-type allelic variants
(from 87.5°C to 88.5°C) (Table
1). These differences
in
Tm will be observed mainly for amplicons generated from
blaIMP-type
genes, since the GC contents of the amplicons generated will
be more divergent than those for
blaVIM-type genes (Table
1).
Allelic variants for the remaining MßL types (blaSPM-1, blaGIM-1, and blaSIM-1) have not been found yet. For this reason, only one clinical isolate harboring blaGIM-1 and one harboring blaSIM-1 were used during the validation process. The theoretical and practical Tm obtained were very similar, and no Tm differences were observed when several genetically unrelated blaSPM-1-harboring P. aeruginosa isolates were submitted to the assay (Table 1).
When the negative-control ATCC reference strains and laboratory strains were submitted to the assay, the melt curve analysis showed only one melting peak varying from 85.5°C to 86.5°C (Table 2). These melting peaks were consistent with the Tm of the amplicon generated by the primers targeting the conserved sequences of the 16S rRNA gene. This internal-control primer pair was used at a lower concentration than the primers targeting the MßL genes; thus, the latter would have preference during the amplification reaction. This strategy was employed to avoid double amplification, which could compromise the melt curve analysis.
The real-time PCR sensitivity experiment showed that the assay was capable of detecting the16S rRNA target gene at a dilution corresponding to 6 x 103 CFU per reaction; blaSPM, blaVIM, blaSIM, and blaIMP at 6 x 102 CFU per reaction; and blaGIM at 6 x 101 CFU per reaction (data not shown). Additionally, the lowest detection limits of the target genes were represented by the cycle threshold values of 34.62, 34.11, 33.66, 32.69, 32.58, and 28.86 for the16S rRNA, blaSPM, blaGIM, blaIMP, blaSIM, and blaVIM genes, respectively. This suggests that the assay as developed is sufficiently robust, even when the bacterial cells suspended in water are used as the template.
Although the assay was developed to detect all MßL-encoding genes, we could not submit strains harboring all the blaIMP and blaVIM allelic variants, since we do not have access to all of them. We also acknowledge the possibility of future assay limitations once more MßL types or newly emerging MßL allelic variants are detected, requiring a possible assay reconfiguration.
The assay was able to detect and identify all MßL-harboring strains evaluated. It is a single-tube reaction, technically simple, performed in only 2 h after colony selection. The Tm-assigned MßL genotypes are easily interpreted (Fig. 1a) and may be suitable for the detection of MßL-producing gram-negative bacteria by molecular diagnostic laboratories. Furthermore, the assay may also be performed through a conventional amplification reaction, followed by visualization of the amplicons by using a UV light box after electrophoresis on a 1.5% agarose gel containing 0.5 µg/ml ethidium bromide (Fig. 1b).
The rapid detection of MßL-producing isolates could
be helpful for epidemiological purposes and for monitoring the
emergence of MßL-producing isolates in clinical settings.
The detection of such isolates could help rapidly establish
standards for hospital infection control measures to minimize
the spreading of these resistant determinants.

ACKNOWLEDGMENTS
We thank Timothy R. Walsh, Mark A. Toleman, Yoshichika Arakawa,
and Yunsop Chong for providing some of the MßL-harboring
clinical isolates included in this study.

FOOTNOTES
* Corresponding author. Mailing address: Division of Infectious Diseases, Federal University of São Paulo, Rua Leandro Dupret, 188, São Paulo, SP, Brazil CEP 04025-010. Phone: (55-11) 5081-2819 or -2965. Fax: (55-11) 5571-5180. E-mail:
rodrigo.mendes{at}lemc.com.br.

Published ahead of print on 8 November 2006. 

REFERENCES
1 - Bahar, G., A. Mazzariol, R. Koncan, A. Mert, R. Fontana, G. M. Rossolini, and G. Cornaglia. 2004. Detection of VIM-5 metallo-ß-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J. Antimicrob. Chemother. 54:282-283.[Free Full Text]
2 - Castanheira, M., M. A. Toleman, R. N. Jones, F. J. Schmidt, and T. R. Walsh. 2004. Molecular characterization of a ß-lactamase gene, blaGIM-1, encoding a new subclass of metallo-ß-lactamase. Antimicrob. Agents Chemother. 48:4654-4661.[Abstract/Free Full Text]
2 - Castanheira, M., R. E. Mendes, R. C. Pição, F. P. Pinto, A. M. O. Machado, T. R. Walsh, and A. C. Gales. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-63, p. 72. ASM Press, Washington, D.C.
3 - Chu, Y. W., M. Afzal-Shah, E. T. Houang, M. I. Palepou, D. J. Lyon, N. Woodford, and D. M. Livermore. 2001. IMP-4, a novel metallo-ß-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents Chemother. 45:710-714.[Abstract/Free Full Text]
4 - Da Silva, G. J., M. Correia, C. Vital, G. Ribeiro, J. C. Sousa, R. Leitao, L. Peixe, and A. Duarte. 2002. Molecular characterization of blaIMP-5, a new integron-borne metallo-ß-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol. Lett. 215:33-39.[Medline]
5 - Docquier, J. D., M. L. Riccio, C. Mugnaioli, F. Luzzaro, A. Endimiani, A. Toniolo, G. Amicosante, and G. M. Rossolini. 2003. IMP-12, a new plasmid-encoded metallo-ß-lactamase from a Pseudomonas putida clinical isolate. Antimicrob. Agents Chemother. 47:1522-1528.[Abstract/Free Full Text]
6 - Galani, I., M. Souli, Z. Chryssouli, D. Katsala, and H. Giamarellou. 2004. First identification of an Escherichia coli clinical isolate producing both metallo-ß-lactamase VIM-2 and extended-spectrum ß-lactamase IBC-1. Clin. Microbiol. Infect. 10:757-760.[CrossRef][Medline]
7 - Gales, A. C., L. C. Menezes, S. Silbert, and H. S. Sader. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-ß-lactamase. J. Antimicrob. Chemother. 52:699-702.[Abstract/Free Full Text]
8 - Lartigue, M. F., L. Poirel, and P. Nordmann. 2004. First detection of a carbapenem-hydrolyzing metalloenzyme in an Enterobacteriaceae isolate in France. Antimicrob. Agents Chemother. 48:4929-4930.[Free Full Text]
9 - Lee, K., J. H. Yum, D. Yong, H. M. Lee, H. D. Kim, J. D. Docquier, G. M. Rossolini, and Y. Chong. 2005. Novel acquired metallo-ß-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.[Abstract/Free Full Text]
10 - Libisch, B., M. Gacs, K. Csiszar, M. Muzslay, L. Rokusz, and M. Fuzi. 2004. Isolation of an integron-borne blaVIM-4 type metallo-ß-lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrob. Agents Chemother. 48:3576-3578.[Abstract/Free Full Text]
11 - Lincopan, N., J. A. McCulloch, C. Reinert, V. C. Cassettari, A. C. Gales, and E. M. Mamizuka. 2005. First isolation of metallo-ß-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J. Clin. Microbiol. 43:516-519.[Abstract/Free Full Text]
12 - Luzzaro, F., J. D. Docquier, C. Colinon, A. Endimiani, G. Lombardi, G. Amicosante, G. M. Rossolini, and A. Toniolo. 2004. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-ß-lactamase encoded by a conjugative plasmid. Antimicrob. Agents Chemother. 48:648-650.[Abstract/Free Full Text]
13 - Mendes, R. E., M. Castanheira, P. Garcia, M. Guzman, M. A. Toleman, T. R. Walsh, and R. N. Jones. 2004. First isolation of blaVIM-2 in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:1433-1434.[Free Full Text]
14 - Mendes, R. E., M. A. Toleman, J. Ribeiro, H. S. Sader, R. N. Jones, and T. R. Walsh. 2004. Integron carrying a novel metallo-ß-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother. 48:4693-4702.[Abstract/Free Full Text]
15 - Osano, E., Y. Arakawa, R. Wacharotayankun, M. Ohta, T. Horii, H. Ito, F. Yoshimura, and N. Kato. 1994. Molecular characterization of an enterobacterial metallo-ß-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob. Agents Chemother. 38:71-78.[Abstract/Free Full Text]
16 - Quinteira, S., J. C. Sousa, and L. Peixe. 2005. Characterization of In100, a new integron carrying a metallo-ß-lactamase and a carbenicillinase, from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:451-453.[Abstract/Free Full Text]
17 - Riccio, M. L., N. Franceschini, L. Boschi, B. Caravelli, G. Cornaglia, R. Fontana, G. Amicosante, and G. M. Rossolini. 2000. Characterization of the metallo-ß-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob. Agents Chemother. 44:1229-1235.[Abstract/Free Full Text]
18 - Riccio, M. L., L. Pallecchi, J. D. Docquier, S. Cresti, M. R. Catania, L. Pagani, C. Lagatolla, G. Cornaglia, R. Fontana, and G. M. Rossolini. 2005. Clonal relatedness and conserved integron structures in epidemiologically unrelated Pseudomonas aeruginosa strains producing the VIM-1 metallo-ß-lactamase from different Italian hospitals. Antimicrob. Agents Chemother. 49:104-110.[Abstract/Free Full Text]
19 - Sader, H. S., M. Castanheira, R. E. Mendes, M. Toleman, T. R. Walsh, and R. N. Jones. 2005. Dissemination and diversity of metallo-ß-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Int. J. Antimicrob. Agents 25:57-61.[CrossRef][Medline]
19 - Sader, H. S., R. Morfin, E. Rodriguez-Noriega, L. M. Deshpande, T. R. Walsh, R. N. Jones. 2005. Abstr. 45th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-99, p. 86. ASM Press, Washington, D.C.
20 - Scoulica, E. V., I. K. Neonakis, A. I. Gikas, and Y. J. Tselentis. 2004. Spread of blaVIM-1-producing E. coli in a university hospital in Greece. Genetic analysis of the integron carrying the blaVIM-1 metallo-ß-lactamase gene. Diagn. Microbiol. Infect. Dis. 48:167-172.[CrossRef][Medline]
21 - Tognim, M. C., A. C. Gales, A. P. Penteado, S. Silbert, and H. S. Sader. 2006. Dissemination of IMP-1 metallo-ß-lactamase-producing Acinetobacter species in a Brazilian teaching hospital. Infect. Control Hosp. Epidemiol. 27:742-747.[CrossRef][Medline]
22 - Toleman, M. A., D. Biedenbach, D. Bennett, R. N. Jones, and T. R. Walsh. 2003. Genetic characterization of a novel metallo-ß-lactamase gene, blaIMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J. Antimicrob. Chemother. 52:583-590.[Abstract/Free Full Text]
23 - Toleman, M. A., D. Biedenbach, D. M. Bennett, R. N. Jones, and T. R. Walsh. 2005. Italian metallo-ß-lactamases: a national problem? Report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 55:61-70.[Abstract/Free Full Text]
24 - Toleman, M. A., K. Rolston, R. N. Jones, and T. R. Walsh. 2004. blaVIM-7, an evolutionarily distinct metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob. Agents Chemother. 48:329-332.[Abstract/Free Full Text]
25 - Toleman, M. A., A. M. Simm, T. A. Murphy, A. C. Gales, D. J. Biedenbach, R. N. Jones, and T. R. Walsh. 2002. Molecular characterization of SPM-1, a novel metallo-ß-lactamase isolated in Latin America: report from the SENTRY Antimicrobial Surveillance Programme. J. Antimicrob. Chemother. 50:673-679.[Abstract/Free Full Text]
26 - Walsh, T. R. 2005. The emergence and implications of metallo-ß-lactamases in Gram-negative bacteria. Clin. Microbiol. Infect. 11(Suppl. 6):2-9.[Medline]
27 - Walsh, T. R., M. A. Toleman, L. Poirel, and P. Nordmann. 2005. Metallo-ß-lactamases: the quiet before the storm? Clin. Microbiol. Rev. 18:306-325.[Abstract/Free Full Text]
28 - Yan, J. J., W. C. Ko, and J. J. Wu. 2001. Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-ß-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 45:2368-2371.[Abstract/Free Full Text]
29 - Yum, J. H., K. Yi, H. Lee, D. Yong, K. Lee, J. M. Kim, G. M. Rossolini, and Y. Chong. 2002. Molecular characterization of metallo-ß-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J. Antimicrob. Chemother. 49:837-840.[Abstract/Free Full Text]
Journal of Clinical Microbiology, February 2007, p. 544-547, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.01728-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Mostachio, A. K., van der Heidjen, I., Rossi, F., Levin, A. S., Costa, S. F.
(2009). Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-{beta}-lactamases in carbapenem-resistant Acinetobacter spp.. J Med Microbiol
58: 1522-1524
[Full Text]
-
Grobner, S., Linke, D., Schutz, W., Fladerer, C., Madlung, J., Autenrieth, I. B., Witte, W., Pfeifer, Y.
(2009). Emergence of carbapenem-non-susceptible extended-spectrum {beta}-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tubingen, Germany. J Med Microbiol
58: 912-922
[Abstract]
[Full Text]
-
Castanheira, M., Bell, J. M., Turnidge, J. D., Mathai, D., Jones, R. N.
(2009). Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-{beta}-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18). Antimicrob. Agents Chemother.
53: 1225-1227
[Abstract]
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Deshpande, L. M., Jones, R. N.
(2009). Codetection of blaOXA-23-Like Gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob. Agents Chemother.
53: 843-844
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Castanheira, M., Jones, R. N.
(2009). Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother
63: 55-59
[Abstract]
[Full Text]
-
Picao, R. C., Andrade, S. S., Nicoletti, A. G., Campana, E. H., Moraes, G. C., Mendes, R. E., Gales, A. C.
(2008). Metallo-{beta}-Lactamase Detection: Comparative Evaluation of Double-Disk Synergy versus Combined Disk Tests for IMP-, GIM-, SIM-, SPM-, or VIM-Producing Isolates. J. Clin. Microbiol.
46: 2028-2037
[Abstract]
[Full Text]
-
Mendes, R. E., Bell, J. M., Turnidge, J. D., Yang, Q., Yu, Y., Sun, Z., Jones, R. N.
(2008). Carbapenem-Resistant Isolates of Klebsiella pneumoniae in China and Detection of a Conjugative Plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 Gene. Antimicrob. Agents Chemother.
52: 798-799
[Full Text]